Terms: = Kidney tumors AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025 AND Treatment
2 results:
1. xpa-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence.
Aufderklamm S; Hennenlotter J; Todenhoefer T; Gakis G; Schilling D; Vogel U; Kuehs U; Dlugosch J; Knapp J; Merseburger A; Gerber V; Ordelheide A; Hevler J; Stenzl A; Schwentner C
World J Urol; 2012 Aug; 30(4):547-52. PubMed ID: 21969130
[TBL] [Abstract] [Full Text] [Related]
2. xpa-210: a new proliferation marker to characterize tumor biology and progression of renal cell carcinoma.
Gakis G; Hennenlotter J; Scharpf M; Hevler J; Schilling D; Kuehs U; Stenzl A; Schwentner C
World J Urol; 2011 Dec; 29(6):801-6. PubMed ID: 21113600
[TBL] [Abstract] [Full Text] [Related]
